Literature DB >> 1504934

Trends in melanoma incidence and mortality.

J A Lee1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1504934     DOI： 10.1016/0738-081x(92)90052-z

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN： 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  2 in total

1.  Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis.

Authors:  Seema Singh; Anguraj Sadanandam; Kalyan C Nannuru; Michelle L Varney; Rosemary Mayer-Ezell; Richard Bond; Rakesh K Singh
Journal:  Clin Cancer Res       Date:  2009-03-17       Impact factor: 12.531

2.  CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion.

Authors:  S Singh; K C Nannuru; A Sadanandam; M L Varney; R K Singh
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.